Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 578


Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.

Takeda T, Tin AL, Corradi RB, Alvim R, Hashimoto T, Ito Y, Nguyen DP, Mamoor M, Robertson NL, Vargas HA, Benfante NE, Sjoberg DD, Eastham JA, Scardino PT, Fine SW, Oya M, Touijer KA.

Int J Urol. 2019 Dec 13. doi: 10.1111/iju.14161. [Epub ahead of print]


Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy.

Mulhall JP, Kattan MW, Bennett NE, Stasi J, Nascimento B, Eastham J, Guillonneau B, Scardino PT.

J Sex Med. 2019 Nov;16(11):1796-1802. doi: 10.1016/j.jsxm.2019.08.003. Epub 2019 Sep 11.


In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.

Ito Y, Vertosick EA, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Eastham JA, Scardino PT, Reuter VE, Fine SW.

Am J Surg Pathol. 2019 Aug;43(8):1061-1065. doi: 10.1097/PAS.0000000000001291.


Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.

Touijer KA, Michaud L, Alvarez HAV, Gopalan A, Kossatz S, Gonen M, Beattie B, Sandler I, Lyaschenko S, Eastham JA, Scardino PT, Hricak H, Weber WA.

Eur Urol Oncol. 2019 Mar;2(2):166-173. doi: 10.1016/j.euo.2018.08.011. Epub 2018 Sep 22.


Reply to Effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer: Do we have certainties today?

Jang TL, Kim IY, Scardino PT, Eastham JA.

Cancer. 2019 Mar 12. doi: 10.1002/cncr.32054. [Epub ahead of print] No abstract available.


Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer.

Ito Y, Udo K, Vertosick EA, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Scardino PT, Eastham JA, Reuter VE, Fine SW.

J Urol. 2019 Mar;201(3):535-540. doi: 10.1016/j.juro.2018.09.060.


Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer.

Jang TL, Patel N, Faiena I, Radadia KD, Moore DF, Elsamra SE, Singer EA, Stein MN, Eastham JA, Scardino PT, Lin Y, Kim IY, Lu-Yao GL.

Cancer. 2018 Oct 15;124(20):4010-4022. doi: 10.1002/cncr.31726. Epub 2018 Sep 25.


Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.

Dean LW, Assel M, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Eastham JA, Scardino PT, Reuter VE, Ehdaie B, Fine SW.

J Urol. 2019 Jan;201(1):77-82. doi: 10.1016/j.juro.2018.07.062.


Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.

Gill IS, Azzouzi AR, Emberton M, Coleman JA, Coeytaux E, Scherz A, Scardino PT; PCM301 Study Group.

J Urol. 2018 Oct;200(4):786-793. doi: 10.1016/j.juro.2018.05.121. Epub 2018 Jun 2.


Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer.

McDevitt MR, Thorek DLJ, Hashimoto T, Gondo T, Veach DR, Sharma SK, Kalidindi TM, Abou DS, Watson PA, Beattie BJ, Timmermand OV, Strand SE, Lewis JS, Scardino PT, Scher HI, Lilja H, Larson SM, Ulmert D.

Nat Commun. 2018 Apr 24;9(1):1629. doi: 10.1038/s41467-018-04107-w.


Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project.

Assel MJ, Gerdtsson A, Thorek DLJ, Carlsson SV, Malm J, Scardino PT, Vickers A, Lilja H, Ulmert D.

Oncotarget. 2017 Dec 5;9(5):5778-5785. doi: 10.18632/oncotarget.22981. eCollection 2018 Jan 19.


Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?

Nguyen DP, Vertosick EA, Sharma V, Corradi RB, Vilaseca A, Takeda T, Sjoberg DD, Benfante N, Fine SW, Reuter VE, Scardino PT, Eastham JA, Karnes RJ, Touijer KA.

J Urol. 2018 Jun;199(6):1502-1509. doi: 10.1016/j.juro.2017.12.056. Epub 2018 Jan 4.


Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.

Touijer KA, Karnes RJ, Passoni N, Sjoberg DD, Assel M, Fossati N, Gandaglia G, Eastham JA, Scardino PT, Vickers A, Cozzarini C, Montorsi F, Briganti A.

Eur Urol. 2018 Jun;73(6):890-896. doi: 10.1016/j.eururo.2017.09.027. Epub 2017 Oct 16.


Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.

Audenet F, Vertosick EA, Fine SW, Sjoberg DD, Vickers AJ, Reuter VE, Eastham JA, Scardino PT, Touijer KA.

J Urol. 2018 Apr;199(4):961-968. doi: 10.1016/j.juro.2017.10.010. Epub 2017 Oct 10.


Topography of Prostate Cancer Recurrence After Radiation Therapy: A Detailed Mapping Study of Salvage Radical Prostatectomy Specimens.

Takeda T, Tin AL, Corradi RB, Mamoor M, Benfante NE, Sjoberg DD, Scardino PT, Eastham JA, Fine SW, Touijer KA.

Eur Urol. 2018 Apr;73(4):488-490. doi: 10.1016/j.eururo.2017.08.005. Epub 2017 Aug 26.


Periprostatic adipose inflammation is associated with high-grade prostate cancer.

Gucalp A, Iyengar NM, Zhou XK, Giri DD, Falcone DJ, Wang H, Williams S, Krasne MD, Yaghnam I, Kunzel B, Morris PG, Jones LW, Pollak M, Laudone VP, Hudis CA, Scher HI, Scardino PT, Eastham JA, Dannenberg AJ.

Prostate Cancer Prostatic Dis. 2017 Dec;20(4):418-423. doi: 10.1038/pcan.2017.31. Epub 2017 Jun 27.


Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy.

Zareba P, Eastham J, Scardino PT, Touijer K.

J Urol. 2017 Nov;198(5):1077-1084. doi: 10.1016/j.juro.2017.06.062. Epub 2017 Jun 15.


Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer.

Shukla-Dave A, Wassberg C, Pucar D, Schöder H, Goldman DA, Mazaheri Y, Reuter VE, Eastham J, Scardino PT, Hricak H.

World J Radiol. 2017 Mar 28;9(3):134-142. doi: 10.4329/wjr.v9.i3.134.


Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.

Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC.

J Urol. 2017 Feb;197(2S):S200-S207. doi: 10.1016/j.juro.2016.10.073. Epub 2016 Dec 22.


Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy.

Nguyen DP, Kent M, Vilaseca A, Corradi RB, Fossati N, Sjoberg DD, Benfante N, Eastham JA, Scardino PT, Touijer KA.

Prostate Cancer Prostatic Dis. 2017 Mar;20(1):105-109. doi: 10.1038/pcan.2016.60. Epub 2016 Dec 13.


Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis.

Thorek DL, Watson PA, Lee SG, Ku AT, Bournazos S, Braun K, Kim K, Sjöström K, Doran MG, Lamminmäki U, Santos E, Veach D, Turkekul M, Casey E, Lewis JS, Abou DS, van Voss MR, Scardino PT, Strand SE, Alpaugh ML, Scher HI, Lilja H, Larson SM, Ulmert D.

Sci Transl Med. 2016 Nov 30;8(367):367ra167.


Implementation of Dynamically Updated Prediction Models at the Point of Care at a Major Cancer Center: Making Nomograms More Like Netflix.

Vickers AJ, Kent M, Scardino PT.

Urology. 2017 Apr;102:1-3. doi: 10.1016/j.urology.2016.10.049. Epub 2016 Nov 24. No abstract available.


A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.

O'Shaughnessy MJ, McBride SM, Vargas HA, Touijer KA, Morris MJ, Danila DC, Laudone VP, Bochner BH, Sheinfeld J, Dayan ES, Bellomo LP, Sjoberg DD, Heller G, Zelefsky MJ, Eastham JA, Scardino PT, Scher HI.

Urology. 2017 Apr;102:164-172. doi: 10.1016/j.urology.2016.10.044. Epub 2016 Nov 22.


Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.

Vickers AJ, Eastham JA, Scardino PT, Lilja H.

Urology. 2016 Sep;95:224. doi: 10.1016/j.urology.2016.05.046. Epub 2016 Jun 1. No abstract available.


Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.

Gugliemetti G, Sukhu R, Conca Baenas MA, Meeks J, Sjoberg DD, Eastham JA, Scardino PT, Touijer K.

Actas Urol Esp. 2016 Sep;40(7):434-9. doi: 10.1016/j.acuro.2016.02.008. Epub 2016 May 13. English, Spanish.


Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study.

Lee DJ, Recabal P, Sjoberg DD, Thong A, Lee JK, Eastham JA, Scardino PT, Vargas HA, Coleman J, Ehdaie B.

J Urol. 2016 Sep;196(3):697-702. doi: 10.1016/j.juro.2016.03.149. Epub 2016 Mar 30.


Author Reply.

Vickers AJ, Eastham JA, Scardino PT, Lilja H.

Urology. 2016 May;91:17-8. doi: 10.1016/j.urology.2015.12.069. Epub 2016 Mar 15. No abstract available.


Nonthermal Ablation by Using Intravascular Oxygen Radical Generation with WST11: Dynamic Tissue Effects and Implications for Focal Therapy.

Kimm SY, Tarin TV, Monette S, Srimathveeravalli G, Gerber D, Durack JC, Solomon SB, Scardino PT, Scherz A, Coleman J.

Radiology. 2016 Oct;281(1):109-18. doi: 10.1148/radiol.2016141571. Epub 2016 Mar 17.


Detection of Lymph Node Metastases with SERRS Nanoparticles.

Spaliviero M, Harmsen S, Huang R, Wall MA, Andreou C, Eastham JA, Touijer KA, Scardino PT, Kircher MF.

Mol Imaging Biol. 2016 Oct;18(5):677-85. doi: 10.1007/s11307-016-0932-2.


Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features.

Recabal P, Assel M, Musser JE, Caras RJ, Sjoberg DD, Coleman JA, Mulhall JP, Parra RO, Scardino PT, Touijer K, Eastham JA, Laudone VP.

J Urol. 2016 Aug;196(2):507-13. doi: 10.1016/j.juro.2016.02.080. Epub 2016 Feb 22.


Successful external validation of a model to predict other cause mortality in localized prostate cancer.

Kent M, Penson DF, Albertsen PC, Goodman M, Hamilton AS, Stanford JL, Stroup AM, Ehdaie B, Scardino PT, Vickers AJ.

BMC Med. 2016 Feb 9;14:25. doi: 10.1186/s12916-016-0572-z.


The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.

Vickers AJ, Eastham JA, Scardino PT, Lilja H.

Urology. 2016 May;91:12-8. doi: 10.1016/j.urology.2015.12.054. Epub 2016 Feb 2.


Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer.

Zelefsky MJ, Poon BY, Eastham J, Vickers A, Pei X, Scardino PT.

Radiother Oncol. 2016 Jan;118(1):85-91. doi: 10.1016/j.radonc.2015.11.035. Epub 2016 Jan 9.


Preoperative Chemoprophylaxis is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism.

Selby LV, Sovel M, Sjoberg DD, McSweeney M, Douglas D, Jones DR, Scardino PT, Soff GA, Fabbri N, Sepkowitz K, Strong VE, Sarkaria IS; MSKCC VTE Task Force.

J Am Coll Surg. 2016 Feb;222(2):129-37. doi: 10.1016/j.jamcollsurg.2015.11.011. Epub 2015 Dec 15.


Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop.

Jarow JP, Ahmed HU, Choyke PL, Taneja SS, Scardino PT.

Urology. 2016 Feb;88:8-13. doi: 10.1016/j.urology.2015.11.018. Epub 2015 Nov 24.


Molecular Profiles of Prostate Cancer: To Treat or Not to Treat.

Sternberg IA, Vela I, Scardino PT.

Annu Rev Med. 2016;67:119-35. doi: 10.1146/annurev-med-060413-112226. Epub 2015 Oct 29. Review.


Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance.

Ehdaie B, Poon BY, Sjoberg DD, Recabal P, Laudone V, Touijer K, Eastham J, Scardino PT.

BJU Int. 2016 Oct;118(4):535-40. doi: 10.1111/bju.13328. Epub 2015 Oct 26.


Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.

Anderson CB, Tin AL, Sjoberg DD, Mulhall JP, Sandhu J, Touijer K, Laudone VP, Eastham JA, Scardino PT, Ehdaie B.

BJU Int. 2016 Jun;117(6B):E46-51. doi: 10.1111/bju.13215. Epub 2015 Jul 20.


Improved Intraoperative Visualization of Nerves through a Myelin-Binding Fluorophore and Dual-Mode Laparoscopic Imaging.

Cotero VE, Kimm SY, Siclovan TM, Zhang R, Kim EM, Matsumoto K, Gondo T, Scardino PT, Yazdanfar S, Laudone VP, Tan Hehir CA.

PLoS One. 2015 Jun 15;10(6):e0130276. doi: 10.1371/journal.pone.0130276. eCollection 2015.


Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.

Bryant RJ, Sjoberg DD, Vickers AJ, Robinson MC, Kumar R, Marsden L, Davis M, Scardino PT, Donovan J, Neal DE, Lilja H, Hamdy FC.

J Natl Cancer Inst. 2015 Apr 11;107(7). pii: djv095. doi: 10.1093/jnci/djv095. Print 2015 Jul.


Preoperative predictive model of recovery of urinary continence after radical prostatectomy.

Matsushita K, Kent MT, Vickers AJ, von Bodman C, Bernstein M, Touijer KA, Coleman JA, Laudone VT, Scardino PT, Eastham JA, Akin O, Sandhu JS.

BJU Int. 2015 Oct;116(4):577-83. doi: 10.1111/bju.13087. Epub 2015 Mar 30.


Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.

Stattin P, Vickers AJ, Sjoberg DD, Johansson R, Granfors T, Johansson M, Pettersson K, Scardino PT, Hallmans G, Lilja H.

Eur Urol. 2015 Aug;68(2):207-13. doi: 10.1016/j.eururo.2015.01.009. Epub 2015 Feb 11.


The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devices.

Anderson CB, Elkin EB, Atoria CL, Eastham JA, Scardino PT, Touijer K.

Prostate Cancer Prostatic Dis. 2015 Mar;18(1):75-80. doi: 10.1038/pcan.2014.49. Epub 2014 Dec 16.


Decade in review-prostate cancer: a decade of progress in detection and treatment.

Ehdaie B, Scardino PT.

Nat Rev Urol. 2014 Nov;11(11):618-20. doi: 10.1038/nrurol.2014.284. Epub 2014 Oct 14. No abstract available.


Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.


Insignificant disease among men with intermediate-risk prostate cancer.

Hong SK, Vertosick E, Sjoberg DD, Scardino PT, Eastham JA.

World J Urol. 2014 Dec;32(6):1417-21. doi: 10.1007/s00345-014-1413-3. Epub 2014 Sep 27.


Organoid cultures derived from patients with advanced prostate cancer.

Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, Dowling C, Wanjala JN, Undvall EA, Arora VK, Wongvipat J, Kossai M, Ramazanoglu S, Barboza LP, Di W, Cao Z, Zhang QF, Sirota I, Ran L, MacDonald TY, Beltran H, Mosquera JM, Touijer KA, Scardino PT, Laudone VP, Curtis KR, Rathkopf DE, Morris MJ, Danila DC, Slovin SF, Solomon SB, Eastham JA, Chi P, Carver B, Rubin MA, Scher HI, Clevers H, Sawyers CL, Chen Y.

Cell. 2014 Sep 25;159(1):176-187. doi: 10.1016/j.cell.2014.08.016. Epub 2014 Sep 4.


Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study.

Ehdaie B, Sjoberg DD, Dalecki PH, Scardino PT, Eastham JA, Amar D.

Can J Anaesth. 2014 Dec;61(12):1068-74. doi: 10.1007/s12630-014-0221-y. Epub 2014 Aug 21.


Supplemental Content

Loading ...
Support Center